1. World Health Organization. Depression. Genebra: WHO; 2008.
2. Parker GB, Brotchie H, Graham RK. Vitamin D and depression. J Affect Disord. 2017;208:56-61.
3. World Health Organization. Depression: fact. Geneva: WHO; 2017. http://www.who.int/mediacentre/factsheets/fs369/en/. Accessed 22 Jun 2018.
4. Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;35(21):1365-72.
5. Schneider B, Weber B, Frensch A, Stein J, Fritz J. Vitamin D in schizophrenia, major depression and alcoholism. J Neural Transm. 2000;107(7):839-42.
6. Kjærgaard M, Joakimsen R, Jorde R. Lowserum 25-hydroxyvitamin D levels are associated with depression in an adult Norwegian population. Psychiatry Res. 2011;190(2-3):221-5.
7. Stokes CS, Grünhage F, Baus C, Volmer DA, Wagenpfeil S, Riemenschneider M, et al. Vitamin D supplementation reduces depressive symptoms in patients with chronic liver disease. Clin Nutr. 2016;35(4):950-7.
8. Bahrami A, Mazloum SR, Maghsoudi S, Soleimani D, Khayyatzadeh SS, Arekhi S. High dose vitamin D supplementation is associated with a reduction in depression score among adolescent girls: a nine-week follow-up study. J Diet Suppl. 2018;15(2):173-182.
9. Jhee JH, Kim H, Park S, Yun H-R, Jung S-Y, Kee YK, et al. Vitamin D deficiency is significantly associated with depression in patients with chronic kidney disease. Plos One. 2017;12(2):e0171009. https://doi.org/10.1371/journal.pone.0171009.
10. Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry. 2008;65(5):508-12.
11. Sepehrmanesh Z, Kolahdooz F, Abedi F, Mazroii N, Assarian A, Asemi Z, et al. Vitamin D supplementation affects the beck depression inventory, insulin resistance, and biomarkers of oxidative stress in patients with major depressive disorder: a randomized, controlled clinical trial. J Nutr. 2016;146(2):243-8.
12. Spedding S. Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients. 2014;6(4):1501-18.
13. Shaffer JA, Edmondson D, Wasson LT, Falzon L, Homma K, Ezeokoli N, et al. Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. Psychosom Med. 2014;76(3):190-6.
14. Pathak S, Nisar MA, Rosenthal DS. Vitamin D deficiency (VDD) and major depressive disorder (MDD): a causal or casual association? J Endrocine Society 2012; SAT-377.
15. Fleck MP, Berlim MT, Lafer B, Sougey EB, Porto JAD, Brasil MA, et al. Revisão das diretrizes da Associação Médica Brasileira para o tratamento da depressão (Versão integral). Rev Bras Psiquiatr. 2009;31 Suppl 1:S7-S17. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462009000500003&lng=en. Accessed 26 Jun 2018.
16. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-9.
17. American College of Cardiology. Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Washington: ACC; 2017.
18. Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune Neto A, et al. Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose. Arq Bras Cardiol. 2017;109(2): Supl 1:1-76.
19. Cesar LA, Ferreira JF, Armaganijan D, Gowdak LH, Mansur AP, Bodanese LC, et al. Diretriz de doença coronária estável. Arq Bras Cardiol. 2014;103(2): Supl 2:1-59.
20. Miranda Jr F, Casella IB, De Luccia N, organizes. Projeto diretrizes SBACV: Doença arterial periferia obstrutiva de membros inferiores: diagnóstico e tratamento. Recife: Sociedade Brasileira de Angiologia e Cirurgia Vascular; 2015.
21. American Heart Association. Ejection fraction heart failure measurement. Dallas: AHA, 2018.
22. Cefalu WT, editor. Standards of medical care in diabetes-2017: American Diabetes Assotiation (ADA). Diabetes Care. 2017;40 Supp 1:S1-S134.
23. Oliveira JEP, Vencio S, organizes. Diretrizes da Sociedade Brasileira de Diabetes (2015-2016). São Paulo: A.C. Farmacêutica; 2016.
24. Maia AL, Scheffel RS, Meyer EL, Mazeto GM, Carvalho GA, Graf H, et al. Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism. Arq Bras Endocrinol Metabol. 2013;57(3):205-32.
25. Brenta G, Vaisman M, Sgarbi JA, Bergoglio LM, Andrada NC, Bravo PP, et al. Clinical practice guidelines for the management of hypothyroidism. Arq Bras Endocrinol Metab. 2013;57(4):265-91.
26. KDIGO clinical practice guideline for the evaluation and management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3(1):1-150.
27. Bandeira F, Griz L, Chaves N, Carvalho NC, Borges LM, Lazaretti-Castro M, et al. Diagnosis and management of primary hyperparathyroidism: a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism. Arq Bras Endocrinol Metab. 2013;57(6):406-24.